Announcing the 32nd Albert B. Sabin Gold Medal and 2025 Sabin Rising Star Awardees
Dr. Katherine O'Brien will receive the Albert B. Sabin Gold Medal and the Rising Star award will be given to Dr. Livancliff Mbianke at a ceremony in May.
Factsheet: Dengue
In recent decades, the incidence of dengue has grown dramatically around the world, with the World Health Organization reporting just over 500,000 global cases in 2000 and more than 5 million in 2019.
Q&A: Behind the Marburg Virus Outbreak in Rwanda
Sabin’s rapid delivery of investigational vaccines during Rwanda’s Marburg outbreak showcased exceptional coordination among all the partners. This Q&A unpacks the timeline, Sabin’s role, the clinical trial, the vaccine candidate, and key lessons for future collaborations.
Local Impact, Global Change
Explore how Sabin’s partners drive impact on the ground. Discover their stories here, and check back for updates on new locations and projects.
Confronting Deadly Diseases
Vaccines are our best defense against disease. Yet, we still have lethal diseases that need a vaccine solution urgently. Sabin’s R&D team is tackling two such threats: Sudan ebolavirus and Marburg virus disease. There are no approved vaccines for either of these viruses which have left behind a trail of outbreaks, ending many lives and livelihoods in Africa. Sabin’s vaccines are in Phase 2 clinical trials in Uganda and Kenya.
Making a Case for Vaccines
We make vaccines more accessible, enable innovation and expand immunization across the globe.